Caryl and Israel Englander Institute for Precision Medicine

The Caryl and Israel Englander Institute for Precision Medicine brings clinicians, basic scientists, pathologists and computational biologists together to pinpoint the molecular underpinnings of disease and discover novel therapies to treat them. The institute uses next-generation sequencing to determine the molecular profile of each patient’s disease and the genetic mutations that drive its growth. It also runs a robust biobanking program and plans to expand precision medicine techniques from cancer diagnosis and care to other areas of clinical relevance. The institute offers continuing medical educational opportunities for faculty and an area of concentration research block for medical students.

News

Closing the Gap: Working to Combat Racial Disparities in Breast Cancer Outcomes

September 6, 2019

Weill Cornell Medicine researchers are working to combat the stark racial disparities in breast cancer outcomes
Precision Medicine Predicts Exceptional Response of Bladder Cancer Patient to Targeted Therapy

June 5, 2019

Findings from a recent study by a team of Weill Cornell Medicine and NewYork-Presbyterian researchers explain why a bladder cancer patient responded exceptionally well to a...
Amazing Things: Ronda Kotelchuck

May 14, 2019

How a patient and her doctor used precision medicine to fight her deadly uterine cancer.